Home > Drug Search >
  • Targets: Dual specificity protein kinase TTK (TTK)
  •   > 
Drug Filter
Category:
chemistry (6) biology (2)
Status:
Phase Ⅱ (4) Phase Ⅰ (4)
Clinical Stage:
Pending (1) Active (7)
Bio-Type:
Animal extract (1) Whole antibody (1)
Company:
Servier (1) XenoPort (1) University of Melbourne (1) Hadassah Medical Organization (1) Immuron (1) La Trobe University (1) Nerviano Medical Sciences (1) Cascadian Therapeutics (1) Celldex (1) Tianjin Chase Sun Pharmaceutical (1) Third Military Medical University (1) ReveraGen BioPharma (1) Virginia Commonwealth University (1) University of Virginia (1) Bayer (2)
Indication:
Non-alcoholic steatohepatitis (1) Breast cancer (1) Duchenne muscular dystrophy (DMD) (1) Alcoholic hepatitis (1) Melanoma (1) Ovarian cancer (1) Prostate cancer (1) Psoriasis (1) Solid tumours (4) Autistic disorder (1) Renal carcinoma (1) Sepsis (1) hematological malignancies (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top